Pharmaceutical Technology® spoke with Nicola Reid, Associate Director Product Management, Endotoxin Products at Charles River Laboratories, to get her perspective on endotoxin testing and USP’s new ...

New standards may help push more drugmakers to use a synthetic product for critical drug safety testing, instead of one made from horseshoe crab blood that has long drawn criticism. The U.S.

Endotoxin testing is a vital component of pharmaceutical, biologic, and medical device quality control, with a direct impact on medication safety. As detection technologies have advanced, the ...

Endotoxins can trigger severe inflammatory responses, which can result in conditions such as organ dysfunction, blood hypercoagulation, and systemic inflammatory response syndrome. These risks make ...

Bacteria can be found everywhere—even sometimes in clean rooms. That’s a problem for manufacturers of drugs and medical devices that are injected or implanted. Even if manufacturers can remove the ...

Next generation robotic endotoxin testing system boosts manufacturing productivity in the lab Automation through robotics represents an evolution of bacterial endotoxin testing and streamlines quality ...

In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...

STEMart now offers Rapid Endotoxin Testing services for the rapid quantitative analysis of endotoxins to help manufacturers make fast, reliable decisions about the safety of medical devices. The ...

Every year in May when high tide coincides with the full moon, horseshoe crabs convene on the beaches of the mid-Atlantic coast to lay millions of eggs. At the same time, migratory shorebirds on their ...